Rocket Pharmaceuticals, Inc.
A securities class action has been filed in the USDC – N.J. against Rocket Pharmaceuticals, Inc. (RCKT) (“Rocket” or the “Company”), on behalf of all persons and entities that purchased or otherwise acquired Rocket common stock between February 27, 2025, and May 26, 2025, both dates inclusive (the “Class Period”). Rocket is a fully […]